Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otakar Čapoun

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Scientific Reports|October 14, 2020
Analysis of expression, epigenetic, and genetic changes of HNF1B in 130 kidney tumoursMichaela Bártů, Jan Hojný, Nikola Hájková, et al.
Scientific Reports|September 3, 2020
HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological studyPavel Dundr, Michaela Bártů, Jan Hojný, et al.
European Urology Focus|November 25, 2018
Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines PanelViktor Soukup, Otakar Čapoun, Daniel Cohen, et al.
European Urology|May 2, 2017
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic ReviewViktor Soukup, Otakar Čapoun, Daniel Cohen, et al.
European Urology Oncology|January 11, 2021
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel StudyBas W G van Rhijn, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology|May 26, 2026
Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development ProcessElke Rammant, Louis Fox, Silva De Padova, et al.
Nature Reviews. Urology|April 1, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensusRoberto Contieri, Paolo Gontero, Rodolfo Hurle, et al.
European Urology|January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelRichard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Urologic Oncology|November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
European Urology Focus|May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Scientific Reports|October 14, 2020
Analysis of expression, epigenetic, and genetic changes of HNF1B in 130 kidney tumoursMichaela Bártů, Jan Hojný, Nikola Hájková, et al.
Scientific Reports|September 3, 2020
HNF1B, EZH2 and ECI2 in prostate carcinoma. Molecular, immunohistochemical and clinico-pathological studyPavel Dundr, Michaela Bártů, Jan Hojný, et al.
European Urology Focus|November 25, 2018
Risk Stratification Tools and Prognostic Models in Non-muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines PanelViktor Soukup, Otakar Čapoun, Daniel Cohen, et al.
European Urology|May 2, 2017
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic ReviewViktor Soukup, Otakar Čapoun, Daniel Cohen, et al.
European Urology Oncology|January 11, 2021
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel StudyBas W G van Rhijn, Anouk E Hentschel, Johannes Bründl, et al.
European Urology Oncology|May 26, 2026
Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development ProcessElke Rammant, Louis Fox, Silva De Padova, et al.
Nature Reviews. Urology|April 1, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensusRoberto Contieri, Paolo Gontero, Rodolfo Hurle, et al.
European Urology|January 9, 2021
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelRichard J Sylvester, Oscar Rodríguez, Virginia Hernández, et al.
Urologic Oncology|November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
European Urology Focus|May 16, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer SpectrumIrene J Beijert, Anouk E Hentschel, Johannes Bründl, et al.
Pageof 3